Somerset Therapeutics Private Limited: Drug Recall

Recall #D-0354-2025 · 03/21/2025

Class II: Risk

Recall Details

Recall Number: D-0354-2025
Classification: Class II
Product Type: Drug
Recalling Firm: Somerset Therapeutics Private Limited
Status: Ongoing
Date Initiated: 03/21/2025
Location: Bengaluru, N/A, India
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 506,080 vials

Reason for Recall

Lack of Assurance of Sterility: Media fill with bacterial contamination

Product Description

Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)

Distribution Pattern

U.S. Nationwide

Other Recalls by Somerset Therapeutics Private Limited

Class II: Risk 03/21/2025

Lack of Assurance of Sterility: Media fill with bacterial contamination
Class II: Risk 03/21/2025

Lack of Assurance of Sterility: Media fill with bacterial contamination
Class II: Risk 03/21/2025

Lack of Assurance of Sterility: Media fill with bacterial contamination
Class II: Risk 03/21/2025

Lack of Assurance of Sterility: Media fill with bacterial contamination

View all recalls by Somerset Therapeutics Private Limited →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.